RenovaCare Announces Successful FDA Meeting

08:30 EST 15 Feb 2018 | Businesswire

This article has expired, however you can still download the PDF.
RenovaCare, Inc., (RCAR), announced today positive outcomes from its pre-submission meeting with the United States Food and Drug Administration (FDA) regarding the RenovaCare SkinGun™ and CellMist™ System for isolating and s...

Other Sources for this Article

RenovaCare Inc.
Drew Danielson, 888-398-0202


More From BioPortfolio on "RenovaCare Announces Successful FDA Meeting"

Quick Search


Relevant Topics

Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...